TetraLogic Pharmaceuticals Corp Buy Hold or Sell Recommendation

TLOGDelisted Stock  USD 0.0001  0.00  0.00%   
Given the investment horizon of 90 days and your typical level of risk aversion, our recommendation regarding TetraLogic Pharmaceuticals Corp is 'Not Rated'. Macroaxis provides TetraLogic Pharmaceuticals buy-hold-or-sell recommendation only in the context of selected investment horizon and investor attitude towards risk assumed by holding TLOG positions.
  
Check out World Market Map to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in persons.
Note, we conduct extensive research on individual companies such as TetraLogic and provide practical buy, sell, or hold advice based on investors' constraints. TetraLogic Pharmaceuticals Corp. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in persons.

Execute TetraLogic Pharmaceuticals Buy or Sell Advice

The TetraLogic recommendation should be used to complement the buy-or-sell advice compiled from the current analysts' consensus on TetraLogic Pharmaceuticals Corp. Macroaxis does not own or have any residual interests in TetraLogic Pharmaceuticals Corp or other equities on which the buy-or-sell advice is provided. Please provide your input below to execute TetraLogic Pharmaceuticals' advice using the current market data and latest reported fundamentals.

Time Horizon

Risk Tolerance

Execute Advice
Sell TetraLogic PharmaceuticalsBuy TetraLogic Pharmaceuticals
Not Rated
For the selected time horizon TetraLogic Pharmaceuticals Corp has a Risk Adjusted Performance of 0.0215, Jensen Alpha of 0.3121, Total Risk Alpha of (2.99) and Treynor Ratio of 0.619
We provide advice to complement the current expert consensus on TetraLogic Pharmaceuticals. Our dynamic recommendation engine harnesses a multidimensional algorithm to analyze the firm's potential to grow using all technical and fundamental data available at the time. To make sure TetraLogic Pharmaceuticals is not overpriced, please validate all TetraLogic Pharmaceuticals fundamentals, including its book value per share, as well as the relationship between the number of employees and working capital . As TetraLogic Pharmaceuticals appears to be a penny stock we also recommend to double-check its ebitda numbers.

TetraLogic Pharmaceuticals Trading Alerts and Improvement Suggestions

TetraLogic Pharmaceuticals is not yet fully synchronised with the market data
TetraLogic Pharmaceuticals has some characteristics of a very speculative penny stock
TetraLogic Pharmaceuticals has a very high chance of going through financial distress in the upcoming years
TetraLogic Pharmaceuticals Corp currently holds 28.33 M in liabilities with Debt to Equity (D/E) ratio of 4.17, indicating the company may have difficulties to generate enough cash to satisfy its financial obligations. TetraLogic Pharmaceuticals has a current ratio of 0.47, indicating that it has a negative working capital and may not be able to pay financial obligations when due. Debt can assist TetraLogic Pharmaceuticals until it has trouble settling it off, either with new capital or with free cash flow. So, TetraLogic Pharmaceuticals' shareholders could walk away with nothing if the company can't fulfill its legal obligations to repay debt. However, a more frequent occurrence is when companies like TetraLogic Pharmaceuticals sell additional shares at bargain prices, diluting existing shareholders. Debt, in this case, can be an excellent and much better tool for TetraLogic to invest in growth at high rates of return. When we think about TetraLogic Pharmaceuticals' use of debt, we should always consider it together with cash and equity.
Net Loss for the year was (49.72 M) with profit before overhead, payroll, taxes, and interest of 0.
TetraLogic Pharmaceuticals Corp currently holds about 5.89 M in cash with (34.89 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.24, which can makes it an attractive takeover target, given it will continue generating positive cash flow.

TetraLogic Pharmaceuticals Returns Distribution Density

The distribution of TetraLogic Pharmaceuticals' historical returns is an attempt to chart the uncertainty of TetraLogic Pharmaceuticals' future price movements. The chart of the probability distribution of TetraLogic Pharmaceuticals daily returns describes the distribution of returns around its average expected value. We use TetraLogic Pharmaceuticals Corp price's Value At Risk and its Upside Potential as a relative measure of the distribution. The graph of the distribution of TetraLogic Pharmaceuticals returns is essential to provide solid investment advice for TetraLogic Pharmaceuticals.
Mean Return
0.38
Value At Risk
-50
Potential Upside
0.00
Standard Deviation
24.81
   Return Density   
       Distribution  
Investment risk management requires an estimate of the probability of extreme price changes. Therefore, the correct representation of the distribution of TetraLogic Pharmaceuticals historical returns presented in an easy-to-digest graphical form helps investors and money managers understand the risk-reward trade-off of different investement strategies.

TetraLogic Pharmaceuticals Market Momentum

Traders often use several daily momentume indicators to supplement a more traditional technical analysis when analyzing securities such as TetraLogic . With many different options, investors must choose the best indicators for them and familiarize themselves with how they work. We suggest combining traditional momentum indicators with more near-term forms of technical analysis such as Accumulation Distribution or Daily Balance Of Power. With their quantitative nature, daily value technical indicators can also be incorporated into your automated trading systems.

About TetraLogic Pharmaceuticals Buy or Sell Advice

When is the right time to buy or sell TetraLogic Pharmaceuticals Corp? Buying financial instruments such as TetraLogic Pink Sheet isn't very hard. However, what challenging for most investors is doing it at the right time to beat the market. Proper market timing is something most people cannot do without sophisticated tools, which help to isolate the right opportunities. Macroaxis provides hands-on modules to deliver winning trades and diversify your portfolios on a daily basis. Most of our advising modules are very easy to use and apply.
Please read more on our stock advisor page.

Use Investing Ideas to Build Portfolios

In addition to having TetraLogic Pharmaceuticals in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.

Did You Try This Idea?

Run Financials ETFs Thematic Idea Now

Financials ETFs
Financials ETFs Theme
ETF themes focus on helping investors to gain exposure to a broad range of assets, diversify, and lower overall costs. The Financials ETFs theme has 45 constituents at this time.
You can either use a buy-and-hold strategy to lock in the entire theme or actively trade it to take advantage of the short-term price volatility of individual constituents. Macroaxis can help you discover thousands of investment opportunities in different asset classes. In addition, you can partner with us for reliable portfolio optimization as you plan to utilize Financials ETFs Theme or any other thematic opportunities.
View All  Next Launch
Check out World Market Map to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in persons.
You can also try the Alpha Finder module to use alpha and beta coefficients to find investment opportunities after accounting for the risk.

Other Consideration for investing in TetraLogic Pink Sheet

If you are still planning to invest in TetraLogic Pharmaceuticals check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the TetraLogic Pharmaceuticals' history and understand the potential risks before investing.
Sync Your Broker
Sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors.
Analyst Advice
Analyst recommendations and target price estimates broken down by several categories
Equity Search
Search for actively traded equities including funds and ETFs from over 30 global markets
Equity Analysis
Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities
Companies Directory
Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals
Idea Analyzer
Analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas
Technical Analysis
Check basic technical indicators and analysis based on most latest market data
Idea Optimizer
Use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio
Portfolio Backtesting
Avoid under-diversification and over-optimization by backtesting your portfolios